Marinaro M - Search Results

1

Strategies for mucosal vaccine development.

Boyaka PN, Marinaro M, Vancott JL, Takahashi I, Fujihashi K, Yamamoto M, van Ginkel FW, Jackson RJ, Kiyono H, McGhee JR. Boyaka PN, et al. Among authors: marinaro m. Am J Trop Med Hyg. 1999 Apr;60(4 Suppl):35-45. doi: 10.4269/ajtmh.1999.60.35. Am J Trop Med Hyg. 1999. PMID: 10344675 Review.

2

Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.

Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PN, Okahashi N, Yamamoto M, Kiyono H, Bluethmann H, Fujihashi K, McGhee JR. Marinaro M, et al. J Immunol. 1995 Nov 15;155(10):4621-9. J Immunol. 1995. PMID: 7594461

3

Mucosal immunity to infection with implications for vaccine development.

Staats HF, Jackson RJ, Marinaro M, Takahashi I, Kiyono H, McGhee JR. Staats HF, et al. Among authors: marinaro m. Curr Opin Immunol. 1994 Aug;6(4):572-83. doi: 10.1016/0952-7915(94)90144-9. Curr Opin Immunol. 1994. PMID: 7946045 Review.

4

The role of Th1 and Th2 cells for mucosal IgA responses.

Yamamoto M, Vancott JL, Okahashi N, Marinaro M, Kiyono H, Fujihashi K, Jackson RJ, Chatfield SN, Bluethmann H, McGhee JR. Yamamoto M, et al. Among authors: marinaro m. Ann N Y Acad Sci. 1996 Feb 13;778:64-71. doi: 10.1111/j.1749-6632.1996.tb21115.x. Ann N Y Acad Sci. 1996. PMID: 8611017 Review.

5

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

Takahashi I, Marinaro M, Kiyono H, Jackson RJ, Nakagawa I, Fujihashi K, Hamada S, Clements JD, Bost KL, McGhee JR. Takahashi I, et al. Among authors: marinaro m. J Infect Dis. 1996 Mar;173(3):627-35. doi: 10.1093/infdis/173.3.627. J Infect Dis. 1996. PMID: 8627026

6

Mucosal immunity: regulation by helper T cells and a novel method for detection.

Jackson RJ, Marinaro M, VanCott JL, Yamamoto M, Okahashi N, Fujihashi K, Kiyono H, Chatfield SN, McGhee JR. Jackson RJ, et al. Among authors: marinaro m. J Biotechnol. 1996 Jan 26;44(1-3):209-16. doi: 10.1016/0168-1656(95)00095-X. J Biotechnol. 1996. PMID: 8717406 Review.

7

Interleukin-12 alters helper T-cell subsets and antibody profiles induced by the mucosal adjuvant cholera toxin.

Marinaro M, Boyaka PN, Jackson RJ, Finkelman FD, Kiyono H, McGhee JR. Marinaro M, et al. Ann N Y Acad Sci. 1996 Oct 31;795:361-5. doi: 10.1111/j.1749-6632.1996.tb52693.x. Ann N Y Acad Sci. 1996. PMID: 8958955

8

Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses.

Marinaro M, Boyaka PN, Finkelman FD, Kiyono H, Jackson RJ, Jirillo E, McGhee JR. Marinaro M, et al. J Exp Med. 1997 Feb 3;185(3):415-27. doi: 10.1084/jem.185.3.415. J Exp Med. 1997. PMID: 9053442 Free PMC article.

9

Helper T subsets and cytokines for mucosal immunity and tolerance.

Vancott JL, Kweon M, Fujihashi K, Yamamoto M, Marinaro M, Kiyono H, McGhee JR. Vancott JL, et al. Among authors: marinaro m. Behring Inst Mitt. 1997 Feb;(98):44-52. Behring Inst Mitt. 1997. PMID: 9382768 Review. No abstract available.

10

Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.

Marinaro M, Boyaka PN, Jackson RJ, Finkelman FD, Kiyono H, Jirillo E, McGhee JR. Marinaro M, et al. J Immunol. 1999 Jan 1;162(1):114-21. J Immunol. 1999. PMID: 9886376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters